Attempt to engage, yet failure to obtain successful bowel cancer screening: more likely in Māori, Pacific peoples, Asians, men and high deprivation areas.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
23 Aug 2024
Historique:
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

In New Zealand, colorectal cancer (CRC) is the second highest cause of cancer death. We sought to characterise a unique population, the individuals who attempt to engage one or multiple times with screening yet fail to ever obtain successful screening. This is a cross-sectional descriptive analysis on data from the New Zealand National Bowel Screening Programme 2012 to 2022. Over 7,000 individuals (1.26% of all participants) have attempted but failed to be successfully screened in the national bowel screening programme. Males compared with females (OR 1.11, 95% CI 1.06-1.17), Asian (OR 1.65, 95% CI 1.55-1.77), Māori (OR 2.07, 95% CI 1.92-2.24) or Pacific peoples (OR 2.30, 95% CI 2.09-2.52) compared with Europeans had greater odds to attempt but fail to be screened. Māori New Zealand Index of Deprivation (NZDep) quintile five (most deprived) had 4.12 (95% CI 3.64-4.67, plt;0.0001) the odds to attempt but fail to be screened compared with European deprivation quintile one participants (least deprived). There are important variations in the failure to successfully receive CRC screening by gender, age, ethnicity, deprivation level and screening year. We suggest drop-off location checking services for all participants are required.

Identifiants

pubmed: 39173162
doi: 10.26635/6965.6351
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-62

Informations de copyright

© PMA.

Déclaration de conflit d'intérêts

CD: received no payments but research is part of contract in employment by Eastern Institute of Technolog. EIT also provided ethical approval. BM: received locality approval from Te Whatu Ora Te Matau a Māui, Hawke’s Bay and has a service contract with the National Bowel Screening Programme.

Auteurs

Chey G Dearing (CG)

Principal Academic, School of Health and Sport Science, School of Nursing, Eastern Institute of Technology, Napier, New Zealand.

Louise O'Connor (L)

Gastroenterology Nurse, Gastroenterology Department, Hawke's Bay Fallen Soldiers' Memorial Hospital, Napier, New Zealand.

Georgia C Dearing (GC)

Health Science Student, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

Bernard McEntee (B)

Consultant General Surgeon, Gastroenterology Department, Hawke's Bay Fallen Soldiers' Memorial Hospital, Napier, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH